SARS-CoV-2 Vaccination Coverage in Italian Children with Celiac Disease
- PMID: 39407910
- PMCID: PMC11477183
- DOI: 10.3390/jcm13195851
SARS-CoV-2 Vaccination Coverage in Italian Children with Celiac Disease
Abstract
Background: Celiac disease (CD) is the most common multisystemic autoimmune disorder affecting the pediatric population. However, little data is available regarding SARS-CoV-2 vaccination coverage in pediatric patients with CD. This study aims to evaluate the adherence to national recommendations for SARS-CoV-2 vaccination in children and adolescents with CD and its variation over time. Methods: We retrospectively analyzed medical charts and electronic registry records of SARS-CoV-2 vaccination of patients aged 0-19 years diagnosed with CD in a tertiary center. The vaccination coverage was evaluated according to age groups (young children, children, and adolescents), considering the patients' eligibility for vaccination at different times. Results: Among the 172 patients enrolled, 44.8% received at least one dose of the SARS-CoV-2 vaccine, showing no significant differences compared to the Italian population of similar age. Vaccination coverage demonstrated a progressive reduction after an initial peak (up to 65.5% in December 2021) concomitant with a gradual extension of vaccinable eligibility and falling SARS-CoV-2 infections. Histological diagnosis and the presence of other associated autoimmune diseases were associated with higher levels of adherence to vaccination. Conclusions: Adherence to the SARS-CoV-2 vaccination in young Italian children with CD was very low, while it was better in adolescents and patients with other associated autoimmune diseases. Vaccine hesitancy remains a concern, particularly among those diagnosed using the biopsy-sparing approach. Hesitancy increased during the pandemic period, suggesting the need for ongoing efforts to improve adherence to SARS-CoV-2 vaccination recommendations.
Keywords: COVID-19; SARS-CoV-2; autoimmunity; celiac disease; gluten; vaccination; vaccine hesitancy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
The Influence of SARS-CoV-2 Pandemic on the Diagnosis of Celiac Disease and Clinical Practice in Pediatric Gastroenterology.Nutrients. 2023 Jan 21;15(3):559. doi: 10.3390/nu15030559. Nutrients. 2023. PMID: 36771266 Free PMC article.
-
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17. J Infect Public Health. 2022. PMID: 35728424 Free PMC article.
-
Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?Ital J Pediatr. 2022 Aug 19;48(1):150. doi: 10.1186/s13052-022-01339-x. Ital J Pediatr. 2022. PMID: 35986340 Free PMC article.
-
Humoral immune response to COVID-19 infection or vaccination among celiac disease patients.Cent Eur J Immunol. 2022;47(3):267-274. doi: 10.5114/ceji.2022.118649. Epub 2022 Aug 17. Cent Eur J Immunol. 2022. PMID: 36817269 Free PMC article.
-
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis.Front Public Health. 2024 Apr 10;12:1338208. doi: 10.3389/fpubh.2024.1338208. eCollection 2024. Front Public Health. 2024. PMID: 38660347 Free PMC article.
References
-
- Crocco M., Malerba F., Calvi A., Zampatti N., Gandullia P., Madeo A., Tappino B., Proietti S., Bonassi S. Health-related quality of life in children with coeliac disease and in their families: A long-term follow-up study. J. Pediatr. Gastroenterol. Nutr. 2024;78:105–112. doi: 10.1002/jpn3.12049. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous